Trials / Unknown
UnknownNCT00532519
Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
Prurigo nodularis (PN) is a common dermatological disorder, manifested as scaly nodules which appear mainly on the extensor surfaces of the limbs. PN may appear secondarily to skin scratching in chronic hepatitis, liver cirrhosis, uremia, hypothyroidism etc. Nevertheless, in many cases no underlying physical disease is present. According to the literature, in fifty percent of the patients there is co-morbidity with depression, anxiety or somatoform disorders. We hypothesize that a group of these patients may benefit from antidepressant therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | citalopram (cipralex) | 10-20 mg/day, for 12 weeks. |
Timeline
- First posted
- 2007-09-20
- Last updated
- 2007-09-20
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00532519. Inclusion in this directory is not an endorsement.